Probiotyki a zywienie czlowieka

• Autorzy: Wozniak-Kosek A , Jarosz M.

Warianty tytułu

EN

Probiotics and human nutrition

• Języki publikacji: PL

Słowa kluczowe

PL

mikroflora jelitowa; zywnosc; Lactobacillus; probiotyki; Bifidobacterium; drozdze; bakterie kwasu mlekowego; zywienie czlowieka

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2005
• Tom: 32
• Numer: 1
• Opis fizyczny: s.72-83,tab.,bibliogr.

Twórcy

autor

Wozniak-Kosek A

• Instytut Zywnosci i Zywienia, Warszawa

autor

Jarosz M.

Bibliografia

• 1. Armuzzi A.: The effect of orał administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment. Pharmacol. Ther., 2001, 15, 163-169.
• 2. Bernet M.F., Brassart D., Neeser J.R.: Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl. Environ. Microbiol., 1993, 59, 4121-4125.
• 3. Cremonini F.: Effect of different probio- tic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am. J. Gastroenterol., 2002, 97, 2744- 2749.
• 4. Coconnier M.H.: Antagonistic activity of Lactobacillus acidophilus LB against intracellular Salmonella enterica serovar Typhimurium infecting human ente- rocyte-like Caco-2/TC-7 cells. Appl. Environ. Microbiol., 1998, 64, 4573-4580.
• 5. Collins M.D., Gibson G.R.: Probiotics, prebiotics, and synbiotics, approaches for modulating the microbial ecology of gut. Am. J. Clin. Nutr., 1999, 69, 5, 1052-1057.
• 6. Costalos C.: Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum. Dev., 2003, 74, 89-96.
• 7. Drouault S., Corthier G.: Health effects of lactic acid bacteria ingested in fermented milk. Vet. Res., 2001, 32, 2, 101-117.
• 8. Ducluzeau R.: Concept of probiotic: History, definition and main characteristics. Antibiotique 2002, 4, 4, 234-238.
• 9. Felley C. P.: Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur. J. Gastroenterol. Hepatol., 2001, 13, 25-29.
• 10. Fuller R.: Probiotics in man and animals. J. Appl. Bact., 1989, 66, 365.
• 11. Goldin B.R., Gorbachs L.: Probiotics for humans. In: Probiotics, the scientific basis. Ed: R. Füller, London, Chapman & Hall Ltd., 1992, 335-376.
• 12. Goldin B.R., Gorbach S.L., Saxelin M.: Survival of Lactobacillus species (strain GG) in human gastrointrstinal tract. Dig. Dis. Sei., 1992, 37, 1, 121-128.
• 13. Guidelines for the Evaluation of Probiotics in Food. Raport a Joint FAO/WHO Working Group. London, Ontario, Canada 2002.
• 14. Hatakka K., Savilathi E., Pönkä A.: Effect of long term consumption of probiotic milk on infections in children attending a day care centres: double lind, randomised trial. Br. Med. J., 2001, 322, 7298, 1327- 1329.
• 15. Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Report of a Joint FAO/WHO Expert Consultation. Cordoba, Argentina 2001.
• 16. Heczko P.B., Strus M., Drzewiecki A.: Probiotyki a zakażenia. Zakażenia 2004, 4, 33-38.
• 17. Hoop-Hoolihann L.: Prophylactic and therapeutic uses of probiotics: a reviev. J. Am. Diet. Assoc., 2001, 101, 229- 238.
• 18. Hozyasz K.: Probiotyki i prebiotyki - nowe propozycje w żywieniu niemowląt. Med. Rodz., 2002, 1, 17.
• 19. Lee Y.K., Poung K.Y.: Competiton for adhes- sion between probiotics and human gastrointestinal pathogens in the presence of carbohydrate. Br. J. Nutr., 2002, 88, 101-108.
• 20. Leplingard A., Oozeer R., Michelin R.: Presistence of living Lactobacillus casei in human stools after regular ingestion of fermented mikl. Poster presented at the 9th European Nutrition Conference, October 1-4 2003, Rome. Italy. Abstract PST 8 Ann. Nutr. Metab., 2003, 47, 6, 645.
• 21. Libudzisz Z.: Mikroflora jelitowa człowieka a probiotyki. Zakażenia 2004, 6, 47-54.
• 22. Mangell P, Nejdfors P., Wang M.: Lactobacillus plantarum 299v inhibits Escherichia coli induced intestinal permeability. Dig. Dis. Sei., 2002, 47, 3, 511- 516.
• 23. Marteau P., Minekus M., Havenaar R.: Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine:validation and the effect of bile. J. Dairy Sei., 1997, 80, 6, 1031-1037. 24. Marteau P, Pochart P, Bouhnik Y.: The fate and effects of transiting nonpathogenic microorganisms in the human intestine. World Rev. Nutr. Diet., 1993, 74, 1-21.
• 25. Marteau P., Rambaud J.C.: Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol. Rev., 1993, 12, 207-220.
• 26. Marteau P, Shanahan F.: Basis aspect and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of ction and side-effects. Best Pract. Res. Clin. Gastroenterol., 2003, 17, 5, 725-740.
• 27. Marteau P., Vesa T.: Pharmacokinetics of probiotics and biotherapeutic agents in humans. Biosci. Microflora 1998, 17, 1-6.
• 28. Martini M.C., Bollewg G.L., Leuitt M.D.: Lactose digestion by yogurt bet-glactosidase influence of pH and microbial cell integrity. Am. J. Clin. Nutr., 1987, 45, 2, 432-436.
• 29. Mercenier A., Pavan S., Pot B:. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr. Pharm. Des., 2003, 9, 2, 175-191.
• 30. Mieczników I.: Prolongation of Live. G.P New York, Putman et Sons, 1907.
• 31. Michetti P: Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) Lai on Helicobacter pylori infection in humans. Digestion 1999, 60, 203-209.
• 32. Midtvedt T., Bjorneklett A., Carlstedt D.B.: The influence of antibiotics upon microflora-associated characteristics in man and mammals. In germ- free research; microflora control and its application to the biomedical science. New York, Alan R Liss Inc, 1985, 241-245.
• 33. Midtvedt T., Carlsted D.B., Höverstad T.: Establishment of a biochemically active intestinal ecosystem in ex-germfree rats. Appl. Environ. Microbiol., 1987, 53, 12, 2866-71.
• 34. Mogensen G.: Food microor- ganisms-health benefits, safety evaluation and strais with documented history of use in foods. Bull-IDF 2002, 377, 4-9.
• 35. Past E.: Probiotyki - zapobieganie infekcjom bakteryjnym i rezystencji. Medicus, Miesięcznik Okręgowej Izby Lekarskiej w Lublinie, 2001, 6-7, 17.
• 36. Peters J.: Species distribution and antibiotic resistance patterns of enterococci isolated from food of animal origin in Germany. Int. J. Food. Microbiol., 2003, 88, 311-314.
• 37. Pochart P., Dewit O., Desjeux J.F.: Viable starter culture, beta galactosiase activity and lactose in duodenum after yogurt ingestion in lactase-dificient humans. Am. J. Clin. Nutr., 1989, 49, 5, 828-831.
• 38. Prost E.K.: Probiotyki. Med. Wet., 1999, 55, 2, 75-79.
• 39. Rachmilewitz D., Karmeli F., Takabayashi K.: Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 2002, 5, 1428-144.
• 40. Rafter J.: Probiotics and colon cancer. Best Pract. Res. Clin. Gastr., 2003,17, 849-859.
• 41. Reid G., Sanders M.E., Gaskins R.: New scientific paradigms for probiotics and prebiotics. J. Clin. Gastoenterolol., 2003, 37, 105-118.
• 42. Salminen M.K.: Lactobacillus bacteremia during a rapid increase in probiotics use of Lactobacillus rhamnosus GG in Finland. Clin. Infect. Dis., 2002, 35, 1155-1160.
• 43. Salminen S. J.: Safety assessment of probiotics and starters In: Fermentation and food safety. Ed: M.R. Adams, M. J. R. Nout. Gaithersburg MD, Aspen 2001, 239-251.
• 44. Saxelin M., Ahokas H., Salmineu S.: Dose responce on the faecal colonisation of Lactobacillus strain GG administered in two different formulations. Microb. Ecol. Health Dis., 1993, 6, 3, 119-122.
• 45. Saxelin M., Pessi T., Salmines S.: Fecal recovery following oral administration of Lactobacillus strain GG (ATTC 53103) in gelatine capsules to health volunters. Int. J. Food. Microbiol., 1995, 15, 2, 199-203.
• 46. Schrezenmeir J., de Vrese M.: Probiotics, prebiotics and synbiotics - approaching a definition. Am. J. Clin Nutr., 2001, 73, 361-364.
• 47. Usajewicz I.: Probiotyki w żywieniu ludzi. Med. Wet., 1999, 55, 2, 80-83.
• 48. Wysocka M.: Probiotyki - nowe obiecujące zastosowanie w terapii. Nowa Pediatria 2001, 3, 26.
• Strony internetowe:
• 49. Lista szczepów probiotycznych (www.usprobiotics.org)
• 50. Lubelski portal medyczny (www.lekarz.lublin.pl)
• 51. Opis projektu badawczego (www.vtt.fi/bel/new/)